PTPN22 and acute kidney injury: To elucidate the effects of RPL11 in AKI pathogenesis, we established a kidney-targeted RPL11-knockdown mouse model using LyP-1 peptide-modified cationic lipid nanoparticles (LNPs) encapsulating si-RPL11.